We are live on ! Find out more
ADMA icon

ADMA Biologics

94 hedge funds and large institutions have $88.7M invested in ADMA Biologics in 2020 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 36 increasing their positions, 22 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 22

0% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 19

1% less funds holding

Funds holding: 9594 (-1)

5.83% less ownership

Funds ownership: 53.54%47.71% (-5.8%)

20% less capital invested

Capital invested by funds: $110M → $88.7M (-$21.6M)

42% less call options, than puts

Call options by funds: $1.15M | Put options by funds: $1.97M

Holders
94
Holders Change
-1
Holders Change %
-1.05%
% of All Funds
1.66%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
36
Reduced
22
Closed
19
Calls
$1.15M
Puts
$1.97M
Net Calls
-$820K
Net Calls Change
-$368K
Name Holding Trade Value Shares
Change
Change in
Stake
Thrivent Financial for Lutherans
26
Thrivent Financial for Lutherans
Minnesota
$378K
Wells Fargo
27
Wells Fargo
California
$351K +$22.1K +10,506 +6%
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$310K -$6.94K -3,300 -2%
Charles Schwab
29
Charles Schwab
California
$307K +$25.4K +12,077 +8%
Group One Trading
30
Group One Trading
Illinois
$305K +$244K +116,018 +288%
Citadel Advisors
31
Citadel Advisors
Florida
$294K +$317K +150,779 New
BFM
32
Boothbay Fund Management
New York
$280K +$112K +53,453 +59%
RJA
33
Raymond James & Associates
Florida
$266K -$95.4K -45,362 -25%
Deutsche Bank
34
Deutsche Bank
Germany
$255K -$101K -48,045 -27%
Russell Investments Group
35
Russell Investments Group
United Kingdom
$241K +$261K +123,968 New
Squarepoint
36
Squarepoint
New York
$238K +$220K +104,595 +591%
AAS
37
Avantax Advisory Services
Texas
$219K -$99.8K -47,500 -30%
AWM
38
AE Wealth Management
Kansas
$215K +$17.9K +8,500 +8%
MWM
39
Meridian Wealth Management
Kentucky
$195K +$84.1K +40,000 +67%
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$194K +$18.8K +8,934 +10%
ECM
41
ExodusPoint Capital Management
New York
$190K +$205K +97,656 New
AllianceBernstein
42
AllianceBernstein
Tennessee
$161K -$54.2K -25,800 -24%
HSA
43
Hussman Strategic Advisors
Maryland
$160K -$37.8K -18,000 -18%
Los Angeles Capital Management
44
Los Angeles Capital Management
California
$143K +$105 +50 +0.1%
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$126K +$12.7K +6,028 +10%
AC
46
Apogem Capital
New York
$106K +$114K +54,240 New
Millennium Management
47
Millennium Management
New York
$102K +$43.1K +20,517 +65%
EGM
48
Engineers Gate Manager
New York
$101K -$1.05K -500 -1%
SC
49
Shay Capital
New York
$98K +$105K +50,000 New
Osaic Holdings
50
Osaic Holdings
Arizona
$86K +$20.5K +9,759 +28%

ADMA Hedge Fund Activity: Q4 2020 in Review

94 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in ADMA Biologics (ADMA) for Q4 2020, worth a combined $88.7M — down 20% from $110M a quarter earlier.

Fund positioning in ADMA was balanced in Q4 2020: 19 funds opened new positions, 19 closed out, 36 added to existing stakes and 22 trimmed.

The largest buyer was J. Goldman & Co, opening a new position worth an estimated $791K. The largest seller was Sphera Funds Management, exiting entirely with an estimated $2.58M sold.

  • 94 institutional investors held ADMA Biologics (ADMA) as of Q4 2020, down from 95 in Q3 2020.
  • Funds reported $88.7M of ADMA Biologics stock for Q4 2020, down 20% quarter-over-quarter.
  • 19 funds opened new ADMA Biologics positions in Q4 2020 and 19 closed out, a net change of 0 holders.
  • The largest ADMA Biologics buyer in Q4 2020 was J. Goldman & Co, an estimated $791K added.
  • The largest ADMA Biologics seller in Q4 2020 was Sphera Funds Management, an estimated $2.58M sold.

Based on aggregated 13F filings for Q4 2020.